申请人:Chen Austin
公开号:US20120202837A1
公开(公告)日:2012-08-09
Renin inhibitors which are spirocyclic piperidine derivatives, of formula (I) and pharmaceutical compositions thereof useful in the treatment of cardiovascular diseases and renal insufficiency, or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable salt of the stereoisomer thereof, wherein: n, for each instance in which it occurs, is independently 0, 1, or 2; W is a five- or six-membered saturated or unsaturated heterocyclic or carbocyclic monocyclic ring, A is (i) a five- or six-membered saturated or unsaturated heterocyclic or carbocyclic monocyclic ring or (ii) a first five- or six-membered saturated or unsaturated heterocyclic or carbocyclic ring which is fused to a second five- or six-membered saturated or unsaturated heterocyclic or carbocyclic ring, V is —(C═O)—, —CH
2
— or ═CH—; U is a bond or —CH2-, or, when V iS ═CH—, U is —CH═; X is ═CH—, ═CF—, ═C(OR
3
)—, or —(C═O)—; and Y is ═CH—, ═CF—, ═N—, or, for the case when X is —(C═O)—, Y is —N(R
3
)—.
Renin抑制剂是一种螺环哌啶衍生物,其化学式为(I),以及其在心血管疾病和肾功能不全治疗中有用的制药组合物,或其立体异构体,或其药学上可接受的盐,或其立体异构体的药学上可接受的盐,其中:n,在每个出现的情况下,独立地为0、1或2;W为五元或六元饱和或不饱和杂环或碳环单环,A为(i)五元或六元饱和或不饱和杂环或碳环单环,或(ii)第一个与第二个五元或六元饱和或不饱和杂环或碳环单环融合的五元或六元饱和或不饱和杂环或碳环单环,V为—(C═O)—、—CH2—或═CH—;U为键或—CH2-,或当V为═CH—时,U为—CH═;X为═CH—、═CF—、═C(OR3)—或—(C═O)—;Y为═CH—、═CF—、═N—,或当X为—(C═O)—时,Y为—N(R3)—。